Table 2.
Race/Ethnicity |
|||||||
---|---|---|---|---|---|---|---|
Variables | Overall | White | Black or African American | Hispanic (any race) | Asian + NHPI1 | Other | P Value2 |
N=24,769 | N=19,232 | N= 1,148 | N= 1,942 | N= 1,524 | N= 923 | ||
Reported Exposure to SARS-CoV-2 virus, n (%) | |||||||
Any Exposure | 11,182 (48·2) | 8,782 (48·1) | 427 (45·5) | 892 (50·7) | 662 (47·2) | 419 (50·7) | 0·046 |
Exposed at work place | 9,902 (42·7) | 7,804 (42·8) | 358 (38·1) | 768 (43·6) | 603 (42·9) | 369 (44·6) | 0·042 |
Exposed in community | 2,359 (10·2) | 1,842 (10·1) | 112 (11·9) | 217 (12·3) | 94 (6·7) | 94 (11·4) | <0·001 |
Exposed at work place among those reported any exposure | 9,902 (88·6) | 7,804 (88·9) | 358 (83·8) | 768 (86·1) | 603 (91·1) | 369 (88·1) | <0·001 |
SARS-CoV-2 Viral Test, n (%) | |||||||
Ever tested (among overall) | 10,164 (41·0) | 7,769 (40·4) | 536 (46·7) | 869 (44·7) | 589 (38·6) | 401 (43·4) | <0·001 |
Tested positive (among overall) | 956 (3·9) | 736 (3·8) | 66 (5·7) | 68 (3·5) | 48 (3·1) | 38 (4·1) | 0·007 |
Tested positive (among tested) | 956 (9·4) | 736 (9·5) | 66 (12·3) | 68 (7·8) | 48 (8·1) | 38 (9·5) | 0·061 |
SARS-CoV-2 Antibody Test, n (%) | |||||||
Ever tested (among overall) | 4,106 (16·6) | 3,227 (16·8) | 145 (12·6) | 337 (17·4) | 230 (15·1) | 167 (18·1) | 0·001 |
Tested positive (among overall) | 484 (2·0) | 354 (1·8) | 25 (2·2) | 58 (3·0) | 29 (1·9) | 18 (2·0) | 0·015 |
Tested positive (among tested) | 484 (11·8) | 354 (11·0) | 25 (17·2) | 58 (17·2) | 29 (12·6) | 18 (10·8) | 0·003 |
Viral or antibody test positive, n (%) | 1,321 (5·3) | 989 (5·1) | 86 (7·5) | 119 (6·1) | 74 (4·9) | 53 (5·7) | 0·004 |
Physician diagnosed COVID-19 Illness without a diagnostic test, n (%) | 346 (1·4) | 227 (1·2) | 22 (1·9) | 53 (2·7) | 27 (1·8) | 17 (1·8) | <0·001 |
Any evidence of SARS-CoV-2 infection or COVID-19 illness, n (%) | 1,602 (6·5) | 1,180 (6·1) | 103 (9·0) | 158 (8·1) | 94 (6·2) | 67 (7·3) | <0·001 |
Non-Hispanic Pacific Islander.
Chi-squared test.